How ought we allocate unanticipated doses of COVID-19 vaccines? A proposal based on experience in the United States, 2020–2022

With vaccination against COVID-19 well underway, providers in the United States (U.S.) found that vials of the Pfizer/BioNTech and Moderna vaccines contained more doses than listed. Because of limited vaccine shelf life, vaccine-providing institutions have thrown extra doses away or quickly distribu...

Descripción completa

Detalles Bibliográficos
Autor principal: Curtis, Henry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Palgrave Macmillan UK 2022
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977561/
https://www.ncbi.nlm.nih.gov/pubmed/35379920
http://dx.doi.org/10.1057/s41271-022-00346-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977561/
https://www.ncbi.nlm.nih.gov/pubmed/35379920
http://dx.doi.org/10.1057/s41271-022-00346-w

Ejemplares similares